相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis
Yunfei Ma et al.
PLATELETS (2021)
Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro
Annemiek Dickhout et al.
PLOS ONE (2021)
Human Galectin-1 in Multiple Cancers: A Privileged Molecular Target in Oncology
Nerella Sridhar Goud et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis
Anne Winther-Larsen et al.
SYSTEMATIC REVIEWS (2021)
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab
Wei-Xiang Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients
Li-Ling Huang et al.
THORACIC CANCER (2021)
New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
Laetitia Gheysen et al.
CELLS (2021)
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
M. Domine et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas
Maria Rodriguez-Remirez et al.
NEUROENDOCRINOLOGY (2020)
Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis
Mitsuyoshi Okazaki et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
Shanmuga Subbiah et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer
Abdullah Sakin et al.
ONCOLOGY RESEARCH AND TREATMENT (2019)
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Zoe Leung et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Prognostic Significance Of Platelet-To-Lymphocyte Ratio (PLR) And Mean Platelet Volume (MPV) During Etoposide-Based First-Line Treatment In Small Cell Lung Cancer Patients
Xia-Bo Shen et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer
Marlid Cruz-Ramos et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
Yao-Tsung Tsai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk
Carlos A. Orozco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis
Rongzu Wu et al.
CANCER CELL INTERNATIONAL (2018)
Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
Nathan A. Koonce et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis
Miao Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model
Aaron J. Scott et al.
PLOS ONE (2017)
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Hariruk Yodying et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Platelets in cancer metastasis: To help the villain to do evil
Nailin Li
INTERNATIONAL JOURNAL OF CANCER (2016)
The prothrombotic activity of cancer cells in the circulation
Annachiara Mitrugno et al.
BLOOD REVIEWS (2016)
PF4 Promotes Platelet Production and Lung Cancer Growth
Ferdinando Pucci et al.
CELL REPORTS (2016)
Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients
Xiaobin Gu et al.
SCIENTIFIC REPORTS (2016)
Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
Maria L. Bacigalupo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
A novel and essential role for FcγRIIa in cancer cell-induced platelet activation
Annachiara Mitrugno et al.
BLOOD (2014)
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri et al.
CANCER TREATMENT REVIEWS (2014)
The Leukocyte Activation Receptor CD69 Controls T Cell Differentiation through Its Interaction with Galectin-1
Hortensia de la Fuente et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
Maria Jose Carlini et al.
LUNG CANCER (2014)
Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
Julia Etulain et al.
PLOS ONE (2014)
Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
Iris A. Schulkens et al.
PLOS ONE (2014)
Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
Tomas Dalotto-Moreno et al.
CANCER RESEARCH (2013)
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Diego J. Laderach et al.
CANCER RESEARCH (2013)
Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
Ya-Ling Hsu et al.
CARCINOGENESIS (2013)
A first-in-man Phase I study of the galectin-1 (gal-1) inhibitor OTX008 given subcutaneously as a single agent to patients with advanced solid tumors.
Jean-Pierre Delord et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito et al.
CANCER AND METASTASIS REVIEWS (2012)
Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
Ling-Yen Chung et al.
CLINICAL CANCER RESEARCH (2012)
Lung Cancer-derived Galectin-1 Enhances Tumorigenic Potentiation of Tumor-associated Dendritic Cells by Expressing Heparin-binding EGF-like Growth Factor
Po-Lin Kuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project
Iolanda Santimone et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation
Natalia Pacienza et al.
FASEB JOURNAL (2008)
Galectin-1: a small protein with major functions
Isabelle Camby et al.
GLYCOBIOLOGY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis
HM Ko et al.
FEBS LETTERS (2005)
Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction
CD Chung et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
